Revenio Group Oyj · OMXHEX:REG1V
Revenio Group Oyj — Q2 2021 Earnings Presentation
10 slides from Revenio Group Oyj's earnings presentation, Aug 5, 2021
Slide 1: Q2/2021: An excellent quarter, supported by very strong growth in imaging devices
JOUNI TOIJALA, CEO ROBIN PULKKINEN, CFO Q2/2021: An excellent quarter, supported by very strong growth in imaging devices Half-year financial report 1 January–30 June 2021 August 5 , 2021 th
Slide 2: Q2/2021: An excellent quarter, supported by strong growth in imaging devices
Q2/2021: An excellent quarter, supported by strong growth in imaging devices Jouni Toijala Robin Pulkkinen CEO CFO H1/2021: Business update H1/2021: Key financials
Slide 3: April – June 2021 highlights
April – June 2021 highlights • An excellent quarter, supported by strong growth in imaging devices – good sales performance in all key markets • Both pent-up demand + gaining market share • Sales efforts in Asia are also paying off despite the N ET SAL ES 18.9 MEUR +37.9% YoY COVID-19 restrictions s
Slide 4: Product update
Product update We improve the quality of clinical diagnostics with targeted product innovations New products are supporting long term growth: • Launch of iCare HOME2 tonometer in March • New iCare PATIENT2 mobile app that allows patients to monitor their IOP results via iOS or Android mobile devices
Slide 5: Robin Pulkkinen, CFO
ROBIN PULKKINEN, CFO Q2/2021: An excellent quarter, supported by very strong growth in imaging devices
Slide 6: Key consolidated figures, EUR million
Key consolidated figures, EUR million 4–6/2021 4–6/2020 Change, % 1–6/2021 1–6/2020 Change, % Net Sales 18.9 13.7 37.9 35.6 25.6 39.2 EBITDA 5.2 4.1 25.4 10.4 7.2 45.3 EBITDA-% 27.4% 30.1% -2.7% 29.3% 28.1% 1.2% Adj EBITDA 5.2 4.1 26.4 11.1 7.2 54.8 Adj EBITDA-% 27.6% 30.1% -2.5% 31.2% 28.1% 3.1% EB
Slide 7: Development of key figures
Development of key figures 100.0 % 84.0 % 81.8 % 78.9 % 80.0 % 60.9 % 61.9 % - Equity ratio has remained 59.5 % 58.6 % Equity ratio % 60.0 % 45.6 % 53.2 % strong 33.3 % 31.0 % 31.2 % 40.0 % 35.5 % 30.1 % 22.6 % 18.1 % 27.3 % Return on - Operative cashflow up 80% 19.4 % 20.7 % Investment % 20.0 % (an
Slide 8: Shareholders 30.6.2021
Shareholders 30.6.2021 Name Num. of shares Change Capital William Der S 2,899,237 10.87% SEB Fun 1,205,203 Columbia Threadneedle 1,157,397 434 Country Capital Group 792,790 2.97% Finland Groupama Asset Management 633,270 % United States 15.93% Vanguard 624,454 9 8 Denmark 11.48% Ilmarinen Mutual Pen
Slide 9: Guidance
Guidance Revenio updates its financial guidance for the year 2021 Revenio Group’s exchange rate adjusted net sales are estimated to grow very strongly from the previous year and profitability is to remain at a good level without non-recurring items. COVID-19 pandemic continues to cause uncertainty r
Slide 10: Financial guidance for 2021 – updated on August 5th, 2021
Financial guidance for 2021 – updated on August 4 , 2021 th “We aspire to keep the wonderful Revenio Group’s exchange rate adjusted world net are estimated to grow very strongly from the sales visible for all” previous year and profitability is to remain at a good level without non-recurring items.